Klonopin (clonazepam) is used to control seizures in epilepsy and for the treatment of panic disorder. Includes side effects, interactions and indications. Klonopin Wafer is a medication used to prevent and treat seizures, panic disorder, anxiety, and the movement disorder known as akathisia. It's used to control seizures or fits due to epilepsy, involuntary muscle spasms and sometimes restless legs syndrome. Klonopin Wafers is a medication used to prevent and treat seizures, panic disorder, anxiety, and the movement disorder known as akathisia. It's used to control seizures or fits due to epilepsy, involuntary muscle spasms and sometimes restless legs syndrome. For anxiety, the most prominent example of this formulation is Klonopin Wafers (clonazepam), primarily used for panic disorder. These wafers dissolve rapidly on the tongue, offering a convenient and fast-acting delivery method for patients who may struggle with traditional tablets. If you are using the disintegrating tablet (wafer), make sure your hands are dry before you handle the tablet. Do not open the blister pack that contains the tablet until you are ready to take it. Get clear safety guidance for KlonoPIN Wafers, including warnings, precautions, when to seek medical assistance, and how to use it correctly. KLONOPIN is a benzodiazepine medicine. Benzodiazepines can cause severe drowsiness, breathing problems (respiratory depression), coma, and death when taken with opioid medicines. KLONOPIN can make you sleepy or dizzy and can slow your thinking and motor skills. This may get better over time. Klonopin Wafers (clonazepam orally disintegrating tablets) are white, round and debossed with the tablet strength expressed as a fraction or whole number (1/8, 1/4, 1/2, 1, or 2). Klonopin wafers will dissolve rapidly in saliva, so water is not necessary (but drinking some is OK). Using dry hands, place the wafer in the mouth immediately after peeling back the foil from the blister pack. It's OK to take Klonopin either with food or without food. Since Klonopin® (clonazepam) was approved on June 4, 1975, we have become aware of new safety information indicating an increased risk of suicidal thoughts and behavior with antiepileptic drugs.